Instrument Inactif

Communiqués Advanced Proteome Therapeutics Corp. Other OTC

Actions

05/12/23	Canadian Investment Regulatory Organization Trading Halt - APC.H	AQ
17/01/23	IIROC Trading Resumption - APC	AQ
17/01/23	IIROC Trading Halt - APC	AQ
04/08/22	ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT	AQ
13/04/22	Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims	NE
24/08/21	Advanced Proteome Therapeutics Provides Update on COVID Program	NE
21/07/21	Advanced Proteome Therapeutics Announces Appointment of Dr. Benjamin Krantz to CEO	NE
09/06/21	Advanced Proteome Therapeutics Announces Renowned Scientist to Join Scientific Advisory Board and New Chemistry Hire	NE
13/04/21	Advanced Proteome Therapeutics Announces Closing Final Tranche of Non-Brokered Private Placement	NE
11/03/21	Advanced Proteome Therapeutics Announces Increase of Non-Brokered Private Placement	NE
01/03/21	Advanced Proteome Therapeutics Announces a Non-Brokered Private Placement	NE
17/12/20	Advanced Proteome Therapeutics : IIROC Trading Resumption - APC	AQ
17/12/20	Advanced Proteome Therapeutics : IIROC Trading Halt - APC	AQ
17/12/20	Advanced Proteome Therapeutics Announces Dr. Benjamin Krantz to Join Company as CEO	NE
14/08/20	Advanced Proteome Therapeutics Provides Project Update	NE
09/07/20	Advanced Proteome Therapeutics : IIROC Trading Resumption - APC	AQ
09/07/20	Advanced Proteome Therapeutics Files Provisional IP for Compounds Targeting SARS-CoV-2	NE
09/07/20	Advanced Proteome Therapeutics : IIROC Trading Halt - APC	AQ
17/02/20	Advanced Proteome Therapeutics : Announces a Non-Brokered Private Placement	AQ